Release date: 2007-07-17 A comprehensive study on the treatment of obstructive sleep apnea-hypopnea syndrome (OSAHS) in children has highlighted the importance of adenoid and tonsil removal as the primary therapeutic approach. While this surgery is widely considered the first-line treatment, outcomes can vary depending on several factors, including obesity, nasal conditions, and improper selection of surgical indications. OSAHS is a common disorder among children, characterized by loud snoring, breathing pauses during sleep, shallow breathing, and frequent episodes of low oxygen levels and high carbon dioxide levels. These nighttime disturbances often lead to daytime sleepiness, cardiovascular issues, and even damage to other organs, significantly impacting a child's quality of life and long-term health. The research, published in the February issue of the Chinese Journal of Otorhinolaryngology Head and Neck Surgery, analyzed data from 243 children treated at Beijing Children’s Hospital between June 2004 and June 2006. The patients underwent pre-surgery and post-surgery sleep studies, with follow-up periods ranging from three to twelve months. Surgical success was evaluated based on symptom improvement, the apnea-hypopnea index (AHI), and oxygen saturation levels. According to the findings, 90.9% of the children showed complete recovery after adenoidectomy and/or tonsillectomy. However, 22 patients had an AHI greater than 5.0 events per hour, and 5 experienced persistent symptoms before improvement. Another 17 patients showed no significant relief. Among these cases, some required additional interventions—such as reoperation for tonsil hypertrophy, medical treatment for nasal diseases, or ventilator support for conditions like pectus excavatum, cerebral palsy, or adenoidal hyperplasia. These results emphasize the need for careful evaluation of each patient and management of underlying complications to optimize surgical outcomes. In conclusion, while adenoid and tonsil removal remains the preferred treatment for pediatric OSAHS, poor results often stem from comorbidities and inappropriate surgical indications. For those who do not respond well to initial procedures, further investigation and targeted therapies can significantly improve effectiveness. This study underscores the importance of a multidisciplinary approach in managing OSAHS in children. ——Midi Medical Network Water Soluble Powder/Powder,Albendazole And Ivermectin Powder,Doxycycline Hyclate Soluble Powder,Pulsatilla Chinensis Sichuan Aibang Weiye Biological Engineering Co., Ltd. , https://www.aibangpharm.com